KYNB
Kyntra Bio, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$8.55
+0.71%Margins
Gross margin
18.2%
EBITDA margin
-2036.1%
EBIT margin
-1101.0%
Net margin
3967.8%
FCF margin
-824.4%
-607.7%
Return on equity
181.2%
Return on assets
168.6%
Return on invested capital
0.04x
Asset turnover
-$38.1M
Cash from operations
$23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026